Immunomodulator with antiviral effect :: Consumers survey results of for 3 quarter of 2013

Consumers survey results of for 3 quarter of 2013 in category

Antiviral medications / Immunomodulator with antiviral effect

The annual ratings by results of Consumers survey calculated as average arithmetic mean rank, obtained in each of 4 quarters of year.

	I quarter (january—march)
	II quarter (april—june)
	III quarter (july—september)
	IV quarter (october—december)

1.	2	Amizon (Farmak)	36.84%	5

2.	4	Афлубін (Perrigo)	31.58%	4.29

3.		Arbidol (OTC-Фарм)	26.32%	3.57

4.	2	Аміксин IC (InterChem)	21.05%	2.86

4.		Анаферон (Materia Medica – Ukraine)	21.05%	2.86

4.	2	Ехінацея Гексал (Sandoz)	21.05%	2.86

7.	4	Імунал (Sandoz)	15.79%	2.14

7.	1	Ехінацея-ратіофарм (ratiopharm)	15.79%	2.14

7.		Кагоцел (Ніармедик Плюс)	15.79%	2.14

10.		Proteflazid (Фітофарм)	10.53%	1.43

10.	4	Імуновіт (GlaxoSmithKline)	10.53%	1.43

10.	4	Гропринозин (Gedeon Richter)	10.53%	1.43

10.	3	Джерело (Екомед)	10.53%	1.43

10.	~	Назоферон (Farmak)	10.53%	1.43

15.	3	Immunoflazid (Ecofarm)	5.26%	0.71

15.		IRS 19 (Abbott Laboratories)	5.26%	0.71

15.	~	Імуно Тайсс (Naturprodukt Vega (Dr. Theiss Naturwaren GmbH))	5.26%	0.71

15.	~	Імуно-тон (Arterium Corporation)	5.26%	0.71

15.	~	Імуно-флора (Медіфлора)	5.26%	0.71

15.	~	Імуноплюс (Київський вітамінний завод)	5.26%	0.71

15.	~	Галавіт (Медікор, Москва)	5.26%	0.71

15.		Енгістол (Heel)	5.26%	0.71

15.		Лавомакс (Nizhpharm)	5.26%	0.71

15.	~	Нуклеїнат (Arterium Corporation)	5.26%	0.71

15.		Оксолін-Дарница (Darnitsa)	5.26%	0.71

–.		Derinat drops (Technomedservice)	0.00%	0

–.		Immustat (Darnitsa)	0.00%	0

–.		Imudon (Abbott Laboratories)	0.00%	0

–.	4	Inmunoflam (Lab. Farmur S.A., Peru)	0.00%	0

–.		Viferon (Feron)	0.00%	0

–.		Альтабор (Борщагівський ХФЗ)	0.00%	0

–.		Ехінал (Ternopharm)	0.00%	0

–.	4	Ехінацин (Madaus)	0.00%	0

–.		Лаферон – ФармБіотек Назальний (Interpharmbiotek)	0.00%	0

–.		Максимун (Genom Biotech)	0.00%	0

–.		Оригінальний Великий Бальзам Біттнеру (Perrigo)	0.00%	0

–.		Пантокрин (Ternopharm)	0.00%	0

–.	4	Респиброн (Mili Healthcare)	0.00%	0

Using this rating is only possible with obligatory link to the source.

This rating was built as a result of the study of social preferences in 2013, under the “Favorites of Success” Contest in Ukraine and it’s the free information. In case of full or partial republishing of the information drawn from this rating, it is obligatory to mention the name of the “Favorites of Success” Contest in printed publications, or put an active hyperlink to this page in the electronic media.

Advanced reporting booklet about the study, including demographics of the respondents, by regional breakdown, information roll-call of ad hoc judges etc, can also be obtained from managers of the contest.